Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
Not yet recruiting · NCT06041490 · Registry updated 2023-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, adenocarcinoma, carcinoma, connective tissue neoplasm, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, osteosarcoma, sarcoma | Not yet recruiting | Phase 2 | 2023-09-18 | NCT06041490 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking Union Medical College Hospital | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH) | Beijing | China | 4 |